Volume 16 Supplement 1

Abstracts from the 7th International Conference on cGMP Generators, Effectors and Therapeutic Implications

Open Access

Enhancement of cAMP-mediated inotropic responses by CNP is regulated differently by PDE2 in normal and failing hearts

  • Silja Meier1, 2Email author,
  • Kjetil Wessel Andressen1, 2,
  • Jan Magnus Aronsen2, 3, 4,
  • Ivar Sjaastad2, 3,
  • Tor Skomedal1, 2,
  • Jan-Bjørn Osnes1, 2,
  • Eirik Qvigstad1, 2,
  • Finn Olav Levy1, 2 and
  • Lise Román Moltzau1, 2
BMC Pharmacology and Toxicology201516(Suppl 1):A66

DOI: 10.1186/2050-6511-16-S1-A66

Published: 2 September 2015

Background

Natriuretic peptide levels are increased in heart failure (HF). Atrial (ANP) and brain (BNP) natriuretic peptide mediate their effects preferentially through the natriuretic peptide receptor (NPR)-A, and C-type natriuretic peptide (CNP) through NPR-B. NPRs are membrane bound guanylyl cyclases that increase cyclic GMP (cGMP) production when activated. We have previously shown that NPR-B stimulation by CNP enhances β1-adrenoceptor (β1-AR)- and 5-HT4 serotonin receptor-mediated signaling in failing hearts, probably through inhibition of phosphodiesterase (PDE) 3, a potential detrimental effect in the failing heart. In this study we examine the role of PDE2 in regulating the CNP-induced enhancement of β1-AR and 5-HT4 signaling in non-failing (Sham) and failing (HF) hearts, as PDE2 is a dual-selective PDE and can potentially be stimulated by cGMP.

Methods

Chronic heart failure was induced in male Wistar rats by 6-week coronary artery ligation. Contractility studies were performed ex vivo in left ventricular muscle strips in the presence of appropriate receptor agonist and antagonists. cGMP measurements were performed on isolated left ventricular cardiomyocytes and PDE activity assays on left ventricular cardiomyocyte homogenates.

Results

CNP, by stimulating NPR-B, was able to enhance β1-AR- and 5-HT4-mediated inotropic responses in Sham and HF left ventricular strips. CNP elicited a similar increase of cGMP in cardiomyocytes from Sham and HF. cGMP reduced the cAMP-PDE activity of PDE3 and increased the cAMP-PDE activity of PDE2 concentration-dependently in cardiomyocyte homogenates in a similar way in Sham and HF. In Sham inhibition of PDE2 by EHNA amplified the CNP-induced enhancement of β1-AR- and 5-HT4-mediated inotropic responses. In HF PDE2 inhibition did not influence the functional effects of CNP despite increasing the cGMP response to the same marked extent as in Sham.

Conclusions

There is a preserved mechanism of CNP-induced enhancement of β1-AR and 5-HT4 in Sham and HF. cGMP levels and cGMP-mediated activation and inhibition of cAMP-PDE activity of PDE2 and PDE3, respectively, are similar in Sham and HF. However, PDE2 seems more involved in regulating the β1-AR and 5-HT4 enhancement in Sham compared to HF, which might reflect differences between Sham and HF in PDE2 expression or compartmentation.

Authors’ Affiliations

(1)
Department of Pharmacology, University of Oslo and Oslo University Hospital
(2)
K.G. Jebsen Cardiac Research Centre and Center for Heart Failure Research, University of Oslo
(3)
Institute for Experimental Medical Research, University of Oslo and Oslo University Hospital
(4)
Bjørknes College

Copyright

© Meier et al. 2015

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement